• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M
Royalties for NFTs: Decrease by 97%

Royalties for NFTs: Decrease by 97%

user avatar

by Max Nevskyi

2 years ago


A Twitter user with the username punk9059 shared a series of tweets discussing the current situation in the non-fungible token (NFT) market and its bullish trend. As an expert and collector, he presented statistics showing that in the first half of 2022, NFT buyers paid over $1 billion in royalties.

However, according to him, this figure fell by 97%. In the last six months, royalties for purchasing NFTs on the Ethereum network amounted to just $29 million. The expert also noted that NFT royalties have been increasing over the past four months, indicating a gradual recovery in market sentiment and efforts by projects to comply with regulatory requirements.

NFTs are unique digital assets that use blockchain technology to verify their uniqueness and authenticity. They can represent images, videos, audio, gaming items, and other files. Unlike traditional cryptocurrencies, each NFT has unique identification characteristics.

An interesting feature of NFTs is the inclusion of royalties, allowing creators to receive a percentage of each subsequent resale of their creations. This provides authors with the opportunity to earn from their digital works even after the initial sale.

Royalties for NFTs are embedded in smart contracts that manage these tokens and are automatically paid out with each resale. However, the application of royalties is not mandatory and depends on the settings of the specific token and the platform on which it is sold. Some platforms charge a fee on sales and distribute it between the author and themselves.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.